Hk Yishengyuan Pharmaceutical Group Limited Company Information

Current Status : Live


Hk Yishengyuan Pharmaceutical Group Limited's Hong Kong CR Number is 2140484. Incorporation Date is 03-SEP-2014. It's Winding up Mode is . Dissolution date is . Hk Yishengyuan Pharmaceutical Group Limited company is of Private company limited by shares Type.
Additional Remarks on the Hk Yishengyuan Pharmaceutical Group Limited company are .

Company Data

CRN2140484
Company NameHK YISHENGYUAN PHARMACEUTICAL GROUP LIMITED
Chinese Name香港易勝源藥業集團有限公司
Active StatusLive
Register of ChargesUnavailable
TypePrivate company limited by shares
See other companies with same Type - Private company limited by shares
Winding Up Mode
Date of Incorporation03-SEP-2014
See companies with same Incorporation Date - 03-SEP-2014
Date of Dissolution
Remarks
Important Note
Tagsyishengyuan   group   pharmaceutical   
Find Similar Companies by these tags.

Company Name History Information :

Effective DatePrevious Name
HK YISHENGYUAN PHARMACEUTICAL GROUP LIMITED03-SEP-2014

FAQs:

When was Hk Yishengyuan Pharmaceutical Group Limited incorporated?

Hk Yishengyuan Pharmaceutical Group Limited was incorporated on 03-SEP-2014 in Hongkong.

What is the type of Hk Yishengyuan Pharmaceutical Group Limited?

Hk Yishengyuan Pharmaceutical Group Limited is classified as Private company limited by shares.

What is the current status of Hk Yishengyuan Pharmaceutical Group Limited Company?

The status of Hk Yishengyuan Pharmaceutical Group Limited is Live.

What is the CR Number of Hk Yishengyuan Pharmaceutical Group Limited?

The CR Number of Hk Yishengyuan Pharmaceutical Group Limited is 2140484.

* We are trying our best to keep all the data correct and up-to-date. It should be noted that it is not the primary source of the information on the company Hk Yishengyuan Pharmaceutical Group Limited. The official registry should always be referred for latest information.

Last Updated on 25-06-2016.

Check other companies added on 25-06-2016

Check out Companies Incorporated on 03-SEP-2014: